Mid-cap Picks With Anil Singhvi: Godrej Agrovet, KVB and Advanced Enzymes - 3 top stocks to buy, says Ambareesh Baliga

In the Special mid-cap stocks segment with Zee Business Managing Editor Anil Singhvi today, market analyst Ambareesh Baliga revealed 3 stocks which he said have the potential to give high returns to investors. Know why he thinks highly of Godrej Agrovet. Also, know which two other companies, having seen a tough time, are now on a rebound and are expected to go through a strong rally.  

Top Stocks To Buy – Godrej Agrovet 

  Baliga picked Godrej Agrovet as his top stock pick with a long term view. The company has diversified business interests including animal feed, crop protection, palm oil, dairy, poultry and processed food. The last quarter results were not as good because of coronavirus pandemic as their meat and poultry business took a hit. The road from here looks good and the company is likely to perform well, he added. The stock is currently trading around Rs 460. EPS for FY22 is expected to be around Rs 18. He puts the target price at Rs 580.   

Watch Zee Business Tweet Video Below:

#SPLMidcapStocks | शॉर्ट टर्म, पोजीशनल और लॉन्ग टर्म के लिए मार्केट एनालिस्ट अंबरीश बलिगा के 3 बेहतरीन मिडकैप PICK#ZBizBazaar #Midcap #MidcapStocks @AnilSinghvi_ @ambareeshbaliga pic.twitter.com/gIi88mWuqt

— Zee Business (@ZeeBusiness) July 31, 2020

   Top Stocks To Buy – Karur Vysya Bank 

He picked Karur Vysya Bank stock with a positional medium term view. The stock is currently trading around Rs 35. The company was not doing too well for the last 1.5-2 years. The March 2020 results show a 39 per cent profit he said. Even the June quarter results were quite strong with a 45 per cent jump in the profits. The gross NPAs have come down. The capital adequacy has improved. The bank has turned around and all the issues are sorted out, he said. The medium term target price is Rs 48.  

See Zee Business Live TV Streaming Below:

Top Stocks To Buy – Advanced Enzymes  

Baliga picked Advanced Enzymes with a short term view. The company has suffered over the last two years because of weak performance of Evox Technology, a company it acquired in Germany. This company did not do too well, previously. The performance of Evox is now improving. The stock has also seen a good momentum over the last 1-2 weeks. On a short term basis the stock may achieve levels around Rs 190-Rs 210. The stock is currently trading around Rs 185.